Ersagun TUĞCUGİL, Ahmet BEŞİR, Ahmet SEN, Başar ERDİVANLI

A retrospective study on the effects of diabetes mellitus on perioperative fibrinogen and bleeding amount in coronary artery bypass surgery patients

Aim: In this study, the effects of changes in the coagulation system of diabetic patients that undergo heart surgery on postoperative bleeding amount and complications was investigated.Material and Methods: A total of 106 patients (35 females, 71 males) were retrospectively examined in the study. Patients were divided into two groups: diabetic (Group D, n = 47) and non-diabetic (Group C, n = 59). Preoperative and postoperative hematologic values, postoperative bleeding, and transfusion amounts of all groups were recorded.Results: Preoperative and postoperative fibrinogen and C-reactive protein (CRP) values in Group D were significantly higher compared to those in Group C (p< 0.05 and p< 0.01, respectively). Postoperative bleeding amount, erythrocyte, and fibrinogen transfusion need were found to be significantly lower in Group D compared to Group C (p = 0.04, p = 0.01, and p< 0.001, respectively).Conclusion: Diabetic patients had decreased amount ofpostoperative bleeding, possibly due to a thrombotic tendency caused by chronic inflammation related to diabetes mellitus.

PDF

___

Hartmann M, Sucker C, Boehm O, et al. Efeects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20:230-41.
Waldén K, Jeppsson A, Nasic S, et al. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg 2014;97:1199-206.
Rich JB. The efficacy and safety of aprotinin use in cardiac surgery. Ann Thorac Surg 1998;66:6-11.
Ranucci M, Baryshnikova E, Castelvecchio S, et al. Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013;96:478-85.
Levy JH, Dutton RP, Hemphill III JC, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010;110:354-64.
Kubal C, Srinivasan AK, Grayson AD, et al.Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005;79:1570-76.
Feng Jun MD, Frank W Sellke M. Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass. Curr Opin Cardiol 2016;31: 618–24.
Potz BA, Scrimgeour LA, Feng J, et al. Diabetes and Cardioplegia. J Nat Sci 2017;3:394:1-6.
Pomero F, Di Minno MN, Fenoglio L, et al. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol 2015;52:1007-16.
Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009;5:245–51.
Gielen C, Dekkers O, Stijnen T, et al. The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2014;18: 292-8.
Camila Takao Lopes, Talita Raquel Dos Santos, Evelise Helena Fadini Reis Brunori, et al. Excessive bleeding predictors after cardiac surgery in adults: integrative review. Clin Nurs 2015;24:046–62.
Rafiq S, Johansson PI, Ostrowski SR, et al. Hypercoagulability in patients undergoing coronary artery bypass grafting: Prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012;41:550-5.
Bochsen L, Nielsen AB, Steinbrüchel DA, Johansson PI. Higher thromboelastograph platelet reactivity in cardiac surgery patients than in blood donors, Scand Cardiovascular J 2007; 41: 321-4.
Sato H, Carvalho G, Sato T. The Association of Preoperative Glycemic Control, Intraoperative Insulin Sensitivity, and Outcomes after Cardiac Surgery, J Clin Endocrinol Metab 2010;95:4338-44.
Kristensen KL, Rauer LJ, Mortensen PE, et al. Reoperation for bleeding in cardiac surgery. Interac cardiovasc Thoracic Surg 2012;14:709-13.
Gatti G, Dell’Angela L, Maschietto L, et al. The impact of diabetes on early outcomes after routine bilateral internal thoracic artery grafting. Heart Lung 2016;25:862-69.
J Bucerius, JF Gummert, T Walther, et al. Diabetes in patients undergoing coronary artery bypass grafting. Impact on perioperative outcome. Zeitschrift für Kardiologie 2005;94:575-82.
Levy JH, Szlam F, Tanaka KA, et al. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012;114: 261-74.
Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7.
Karlsson M, Ternstrom L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48:2152-8.
Devaraj S, Siegel D, Jialal I. Statin therapy in metabolic syndrome and hypertension post-jupiter: what is the value of CRP? Curr Atheroscler Rep 2011;13:31-42.
Tantry US, Bliden KP, Suarez TA, et al. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the thrombotic risk progression (TRIP) study. Platelets 2010;21:360-7.
Gurbel PA, Bliden KP, Kreutz RP, et al. The link between heightened thrombogenicity and inflammation: preprocedure characterization of the patient at high risk for recurrent events after stenting. Platelets 2009;20:97-104.
Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 2009;10:554-63.
Santilli F, Vazzana N, Liani R, et al. Platelet activation in obesity and metabolic syndrome. Obes Rev. 2012;13:27-42.
Karkouti K, O’Farrell R, Yau TM. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth 2006;53:781-94.
Lopes CT, Brunori EF, Cavalcante AM, Factors associated with excessive bleeding after cardiac surgery: A prospective cohort study. Heart Lung 2016;45:64-9.
Jimenez Rivera JJ, Iribarren JL, Raya JM, et al. Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study. J Cardiothorac Surg 2007;2: 17.
Dhawale S, Jayant S, Gupta, AK. Serum fibrinogen level in type 2 diabetes mellitus patients. Int J Advan Med 2016;3:83-7.